Amylyx Pharmaceuticals Inc (AMLX)
2.03
+0.03
(+1.50%)
USD |
NASDAQ |
May 03, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Cash from Investing (Quarterly): 20.92M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.92M |
| September 30, 2023 | -108.09M |
| June 30, 2023 | 123.22M |
| March 31, 2023 | 55.99M |
| December 31, 2022 | -228.18M |
| September 30, 2022 | 84.04M |
| Date | Value |
|---|---|
| June 30, 2022 | 4.462M |
| March 31, 2022 | -99.31M |
| December 31, 2021 | 2.814M |
| September 30, 2021 | -49.21M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.014M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-228.18M
Minimum
Dec 2022
123.22M
Maximum
Jun 2023
-16.11M
Average
1.407M
Median
Cash from Investing (Quarterly) Benchmarks
| Cassava Sciences Inc | -0.041M |
| iRhythm Technologies Inc | 1.40M |
| Bristol-Myers Squibb Co | -19.62B |
| Moderna Inc | 118.00M |
| ACADIA Pharmaceuticals Inc | -0.347M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 13.55M |
| Cash from Financing (Quarterly) | 0.23M |
| Free Cash Flow | 10.68M |
| Free Cash Flow Per Share (Quarterly) | 0.1898 |
| Free Cash Flow to Equity (Quarterly) | 13.20M |
| Free Cash Flow to Firm (Quarterly) | 13.20M |
| Free Cash Flow Yield | 7.51% |